Experimental Gene Therapy for Human Colorectal Carcinoma Cells by Cell Type-specific Expression of Suicide Genes
DOI:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The expression plasmid PCEA-TK or pCEA-CD was constructed by ligating the CEA gene promoter to suicide gene such as HSV-TK (herpes simplex virus thymidine kinase) gene or EC-CD (E. coli cytosine deaminase) gene. A human colorectal carcinoma cell line LoVo or a human uterine cervical cancer cell line HeLa was co-transfected with pSV2-neo and PCEA-TK (or PCEA-CD). After selection with G418, the transgenetic cell clones (hoVo/CEA-TK,LoVo/CEA-CD, HeLa/CEA-TK and HeLa/CEA-CD) were obtained. There was no significant difference in either morphology or cell growth curve between suicide gene transduced cells and wild type cells. But LoVo/CEA-TK (or LoVo/CEA-CD) cells were 2000(or 700) times more sensitive to the cytotoxicity of prodrug ganciclovir(or S-Fluorocytosine)than parental LoVo cells. However, HeLa/CEA-TK or HeLa/CEA-CD cells were still resistant to Ganciclovir (or 5-Fluorocytosine). These results showed the possibility of gene therapy for human colorectal carcinoma by cell type-specific expression of suicide genes.

    Reference
    Related
    Cited by
Get Citation

Jiang Qiong, Ge Kai, Xu Dehua, Zheng Zhongcheng, Liu Xinyuan. Experimental Gene Therapy for Human Colorectal Carcinoma Cells by Cell Type-specific Expression of Suicide Genes[J]. Progress in Biochemistry and Biophysics,1996,23(4):376-378

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 26,1996
  • Revised:May 20,1996
  • Accepted:
  • Online:
  • Published: